New Times,
New Thinking.

  1. Science & Tech
1 March 2011updated 04 Oct 2023 10:27am

WikiLeaks nominated for Nobel Peace Prize

The whistleblowing website is one of 241 nominees for the annual award.

By Duncan Robinson

The whistleblowing website WikiLeaks has today been nominated for the Nobel Peace Prize.

The nomination comes after a stellar year for the anti-secrecy site, which became a household name after releasing the Afghanistan and Iraq war logs and, more recently, more than 250,000 US diplomatic cables.

In recent months, however, an increasing number of allegations against the website’s founder, Julian Assange, have overshadowed the site’s achievements.

Today’s announcement comes just days after Assange lost his fight against extradition to Sweden, to face allegations of rape and sexual molestation. New allegations also appeared today in Private Eye, which claims that Assange blames his plight on three journalists – Alan Rusbridger, David Leigh and the former editor of the New Statesman John Kampfner – all of whom, Assange claimed falsely, “were Jewish”.

Select and enter your email address Your weekly guide to the best writing on ideas, politics, books and culture every Saturday. The best way to sign up for The Saturday Read is via saturdayread.substack.com The New Statesman's quick and essential guide to the news and politics of the day. The best way to sign up for Morning Call is via morningcall.substack.com
Visit our privacy Policy for more information about our services, how Progressive Media Investments may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications.
THANK YOU

The other nominees for the prize include the Afghan rights advocate Sima Samar, the European Union, the former German chancellor Helmut Kohl, the Cuban dissident Oswaldo Paya Sardinas, and the Russian rights group Memorial as well as its founder, Svetlana Gannushkina.

Content from our partners
No health, no growth
Tackling cancer waiting times
Kickstarting growth: will complex health issues be ignored?